(HealthDay)—Ertugliflozin appears safe and effective at improving long-term glycemic control among adults with type 2 diabetes mellitus (T2DM) inadequately controlled […]
FRIDAY, Oct. 19, 2018 — Contrary to the advice most cancer patients receive, light or moderate use of topical agents […]
We and our partners use cookies on this site to improve our service, perform analytics, personalize advertising, measure advertising performance, and remember website preferences.Ok